AstraZeneca to Pay $5+ mm to Settle Foreign Bribery Charges

Pharmaceutical giant AstraZeneca PLC agreed to pay $5.5 million to settle foreign bribery charges involving foreign officials in China and Russia. The company appears to have been given a break on fines because of its cooperation in the investigation. The fines were levied by the Securities and Exchange Commission (SEC) pursuant to the Foreign Corrupt Practices Act.Read the full article